Piramal Pharma Ltd share price was down by -7.81% from the previous closing price of ₹200.56. Who are peers of Piramal Pharma Ltd? The peers of Piramal Pharma Ltd are Sun Pharmaceuticals ...

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the ...

In a report released yesterday, Gavin Clark-Gartner from Evercore ISI maintained a Buy rating on Ascendis Pharma (ASND – Research Report), with a price target of $220.00. The company’s shares ...

MILAN, Feb. 12, 2025 /PRNewswire/ -- DOC, an Italian pharmaceutical company specialized in the marketing of generic drugs, expands its strategy by broadening its business lines and defines a new ...

RBC Capital analyst Luca Issi maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) yesterday and set a price target of $77.00. The company’s shares closed yesterday at ...

Nvidia exited its positions in several AI stocks in Q4, but maintained its stake in Recursion Pharmaceuticals. Many investors seemed to view this as a vote of confidence from Nvidia for Recursion.

DOC Pharma strengthens its offerings with the acquisition of the Geopharma nutraceuticals portfolio, and the closing of the previously announced acquisition of Muscoril® New brand identity ...

– Expected use of approximately $25 million in first quarter of 2025 intended to preserve approximately 200,000 ADSs held as treasury shares COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE ...

Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, TransCon, SKYTROFA®, and YORVIPATH® are trademarks owned by the Ascendis Pharma group.

Piramal Pharma Limited was incorporated on March 4 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...